zenocutuzumab,rovalpituzumab tesirine
merus
['zenocutuzumab', 'meru', 'merus']
merus presents clinical data on zenocutuzumab (zeno) in nrg1-fusion (nrg1+) cancer at the 2022 american society of clinical oncology (asco) annual meeting (oral #business
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.